Dilip Shah
Keine laufenden Positionen mehr
Profil
Dilip Shah is the founder of Peptyde Bio, Inc. which was founded in 2022.
Ehemalige bekannte Positionen von Dilip Shah
| Unternehmen | Position | Ende |
|---|---|---|
Peptyde Bio, Inc.
 Peptyde Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Invaio Sciences, Inc., Peptyde Bio, Inc. is an agtech startup that discovers, designs, and characterizes novel anti-microbial peptides. The company is based in Olivette, MO. These peptides can complement or replace chemical fungicides because they are effective, environmentally friendly, and have a lower cost of development compared to traditional fungicides. The company was founded in 2022 by Dilip Shah and Kirk Czymmek. Peptyde Bio was acquired by Invaio Sciences, Inc. from Danforth Technology Co. on December 07, 2023. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Peptyde Bio, Inc.
Peptyde Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Invaio Sciences, Inc., Peptyde Bio, Inc. is an agtech startup that discovers, designs, and characterizes novel anti-microbial peptides. The company is based in Olivette, MO. These peptides can complement or replace chemical fungicides because they are effective, environmentally friendly, and have a lower cost of development compared to traditional fungicides. The company was founded in 2022 by Dilip Shah and Kirk Czymmek. Peptyde Bio was acquired by Invaio Sciences, Inc. from Danforth Technology Co. on December 07, 2023. | Commercial Services |
